441 related articles for article (PubMed ID: 12413371)
1. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.
Zandi PP; Carlson MC; Plassman BL; Welsh-Bohmer KA; Mayer LS; Steffens DC; Breitner JC;
JAMA; 2002 Nov; 288(17):2123-9. PubMed ID: 12413371
[TBL] [Abstract][Full Text] [Related]
2. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.
Zandi PP; Sparks DL; Khachaturian AS; Tschanz J; Norton M; Steinberg M; Welsh-Bohmer KA; Breitner JC;
Arch Gen Psychiatry; 2005 Feb; 62(2):217-24. PubMed ID: 15699299
[TBL] [Abstract][Full Text] [Related]
3. Incidence of AD may decline in the early 90s for men, later for women: The Cache County study.
Miech RA; Breitner JC; Zandi PP; Khachaturian AS; Anthony JC; Mayer L
Neurology; 2002 Jan; 58(2):209-18. PubMed ID: 11805246
[TBL] [Abstract][Full Text] [Related]
4. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.
Zandi PP; Anthony JC; Khachaturian AS; Stone SV; Gustafson D; Tschanz JT; Norton MC; Welsh-Bohmer KA; Breitner JC;
Arch Neurol; 2004 Jan; 61(1):82-8. PubMed ID: 14732624
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype and mortality: findings from the Cache County Study.
Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC;
J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.
Khachaturian AS; Corcoran CD; Mayer LS; Zandi PP; Breitner JC;
Arch Gen Psychiatry; 2004 May; 61(5):518-24. PubMed ID: 15123497
[TBL] [Abstract][Full Text] [Related]
7. Occupational exposure to pesticides increases the risk of incident AD: the Cache County study.
Hayden KM; Norton MC; Darcey D; Ostbye T; Zandi PP; Breitner JC; Welsh-Bohmer KA;
Neurology; 2010 May; 74(19):1524-30. PubMed ID: 20458069
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women.
Lindblad BE; Håkansson N; Philipson B; Wolk A
Ophthalmology; 2010 Mar; 117(3):424-30. PubMed ID: 20045566
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
11. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study.
Carlson MC; Zandi PP; Plassman BL; Tschanz JT; Welsh-Bohmer KA; Steffens DC; Bastian LA; Mehta KM; Breitner JC;
Neurology; 2001 Dec; 57(12):2210-6. PubMed ID: 11756599
[TBL] [Abstract][Full Text] [Related]
13. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.
Shao H; Breitner JC; Whitmer RA; Wang J; Hayden K; Wengreen H; Corcoran C; Tschanz J; Norton M; Munger R; Welsh-Bohmer K; Zandi PP;
Neurology; 2012 Oct; 79(18):1846-52. PubMed ID: 23100399
[TBL] [Abstract][Full Text] [Related]
14. Dementia and Alzheimer disease incidence: a prospective cohort study.
Kukull WA; Higdon R; Bowen JD; McCormick WC; Teri L; Schellenberg GD; van Belle G; Jolley L; Larson EB
Arch Neurol; 2002 Nov; 59(11):1737-46. PubMed ID: 12433261
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.
Khachaturian AS; Zandi PP; Lyketsos CG; Hayden KM; Skoog I; Norton MC; Tschanz JT; Mayer LS; Welsh-Bohmer KA; Breitner JC
Arch Neurol; 2006 May; 63(5):686-92. PubMed ID: 16533956
[TBL] [Abstract][Full Text] [Related]
17. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
19. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction.
Yaffe K; Haan M; Byers A; Tangen C; Kuller L
Neurology; 2000 May; 54(10):1949-54. PubMed ID: 10822435
[TBL] [Abstract][Full Text] [Related]
20. A population study of Alzheimer's disease: findings from the Cache County Study on Memory, Health, and Aging.
Tschanz JT; Treiber K; Norton MC; Welsh-Bohmer KA; Toone L; Zandi PP; Szekely CA; Lyketsos C; Breitner JC;
Care Manag J; 2005; 6(2):107-14. PubMed ID: 16544872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
